Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: Good Manufacturing Practice (GMP)

The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks

Posted on January 5, 2025 By digi

The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks Introduction to PMDA GMP and Risk Management in Pharmaceutical Manufacturing Pharmaceutical manufacturing is an intricate process that involves numerous risks, from raw material sourcing to final product distribution. These risks can include contamination, equipment failures,…

Read More “The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks” »

PMDA GMP Guidelines

Understanding the FDA’s 21 CFR Part 210 and 211 GMP Guidelines

Posted on January 4, 2025 By digi

Understanding the FDA’s 21 CFR Part 210 and 211 GMP Guidelines Comprehensive Guide to FDA’s 21 CFR Part 210 and 211 GMP Guidelines Introduction to 21 CFR Part 210 and 211 The U.S. Food and Drug Administration (FDA) has established stringent regulations to ensure the safety, quality, and efficacy of pharmaceutical products. The Good Manufacturing…

Read More “Understanding the FDA’s 21 CFR Part 210 and 211 GMP Guidelines” »

FDA GMP Guidelines

A Guide to Achieving Health Canada GMP Compliance in Pharma

Posted on January 4, 2025 By digi

A Guide to Achieving Health Canada GMP Compliance in Pharma Comprehensive Guide to Achieving Health Canada GMP Compliance for Pharmaceutical Manufacturers Introduction to Health Canada GMP Compliance Achieving compliance with Health Canada’s Good Manufacturing Practices (GMP) regulations is a crucial milestone for pharmaceutical manufacturers operating in or exporting to Canada. These regulations set rigorous standards…

Read More “A Guide to Achieving Health Canada GMP Compliance in Pharma” »

Health Canada GMP Regulations

How to Address Non-Conformities Identified During Schedule M (Revised) Inspections

Posted on January 4, 2025 By digi

How to Address Non-Conformities Identified During Schedule M (Revised) Inspections Effective Strategies to Resolve Non-Conformities in Schedule M (Revised) GMP Inspections Introduction to Non-Conformities in GMP Inspections Non-conformities identified during Schedule M (Revised) inspections can significantly impact pharmaceutical manufacturing operations. These findings, which highlight deviations from Good Manufacturing Practices (GMP), pose risks to product quality,…

Read More “How to Address Non-Conformities Identified During Schedule M (Revised) Inspections” »

SCHEDULE - M - Revised

How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing

Posted on January 4, 2025 By digi

How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing Introduction to NMPA GMP and Technological Advancements As the pharmaceutical industry continues to grow and evolve, there is an increasing reliance on advanced technology to meet the rising demand for high-quality,…

Read More “How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing” »

NMPA GMP Guidelines

The Impact of PMDA GMP Compliance on Pharma Product Launches

Posted on January 4, 2025 By digi

The Impact of PMDA GMP Compliance on Pharma Product Launches The Impact of PMDA GMP Compliance on Pharma Product Launches Introduction to PMDA GMP and Product Launches The pharmaceutical industry is a highly regulated sector, with strict guidelines in place to ensure that drugs are safe, effective, and manufactured under controlled conditions. In Japan, the…

Read More “The Impact of PMDA GMP Compliance on Pharma Product Launches” »

PMDA GMP Guidelines

How to Achieve FDA GMP Compliance for Drug Development

Posted on January 4, 2025 By digi

How to Achieve FDA GMP Compliance for Drug Development Achieving FDA GMP Compliance in Drug Development: A Comprehensive Guide Introduction to FDA GMP Compliance The journey from concept to market for a pharmaceutical product is long and complex, requiring strict adherence to quality standards at every stage. The U.S. Food and Drug Administration (FDA)’s Good…

Read More “How to Achieve FDA GMP Compliance for Drug Development” »

FDA GMP Guidelines

How Health Canada GMP Regulations Ensure Drug Safety and Quality

Posted on January 4, 2025 By digi

How Health Canada GMP Regulations Ensure Drug Safety and Quality How Health Canada GMP Regulations Safeguard Drug Safety and Quality Introduction to Health Canada GMP Ensuring drug safety and quality is a cornerstone of the pharmaceutical industry, directly impacting patient health and public trust. Health Canada’s Good Manufacturing Practices (GMP) regulations are a critical framework…

Read More “How Health Canada GMP Regulations Ensure Drug Safety and Quality” »

Health Canada GMP Regulations

How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing

Posted on January 4, 2025 By digi

How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing Introduction to NMPA GMP and Pharmaceutical Manufacturing The pharmaceutical industry faces growing pressure to produce safe, effective, and high-quality products while keeping costs manageable and improving operational efficiency. In China, the National Medical…

Read More “How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing” »

NMPA GMP Guidelines

Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals

Posted on January 4, 2025 By digi

Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals Ensuring Compliance with Schedule M (Revised) GMP in Biopharmaceutical Manufacturing Introduction to Biopharmaceuticals and GMP Compliance Biopharmaceuticals represent a rapidly growing segment of the pharmaceutical industry, offering innovative therapies for complex diseases such as cancer, autoimmune disorders, and genetic conditions. However, their production involves…

Read More “Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 … 26 27 28 … 66 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog

Good Manufacturing Practice (GMP)

  • How to Address GMP Non-Compliance in IMP Manufacturing During Clinical Trials: Ensuring Audit Readiness
  • The Benefits of Integrating GMP in the Preclinical Phase of Drug Development
  • How to Address GMP Non-Compliance in IMP Manufacturing During Clinical Trials (SOP perspective)
  • The Link Between GMP and Drug Development Innovation
  • How to Address GMP Non-Compliance in IMP Manufacturing During Clinical Trials
  • How GMP Facilitates the Transition from Research to Full-Scale Manufacturing in Drug Development
  • How GMP Ensures the Ethical and Regulatory Compliance of IMPs in Clinical Research
  • How GMP Contributes to the Speed and Efficiency of Drug Development
  • How GMP Ensures the Ethical and Regulatory Compliance of IMPs in Clinical Research
  • The Role of GMP in Developing Biosimilars and Biologic Drugs

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme